6.5 C
New York
Friday, June 18, 2021

Scientists Manage to Activate HIV Immunity

Must Read

Jiya Saini
Jiya Saini is a Journalist and Writer at Revyuh.com. She has been working with us since January 2018. After studying at Jamia Millia University, she is fascinated by smart lifestyle and smart living. She covers technology, games, sports and smart living, as well as good experience in press relations. She is also a freelance trainer for macOS and iOS, and In the past, she has worked with various online news magazines in India and Singapore. Email: jiya (at) revyuh (dot) com

The study authors believe that bnAb antibodies could be used against other complex pathogens such as influenza, Zika virus, dengue fever, hepatitis C, and so on.

Scientists have completed the first phase of clinical trials of a vaccine against human immunodeficiency virus (HIV). The research results showed that the drug stimulated the production of the rarest immune cells in volunteers, which trigger the production of broad-spectrum antibodies that supposedly successfully suppress the virus. 

This was announced in a press release from the Scripps Research Medical Center and International AIDS Society HIV Research for Prevention (HIVR4P).

Broadly neutralizing antibodies (bnAb) attach to the spikes of HIV particles (these spikes are made up of proteins that are “armor” from the immune system) and disable them. Such antibodies target hard-to-reach areas on the surface of particles – those that do not mutate so strongly and quickly, and therefore, plus or minus are the same in all variants of HIV.

As the scientists note, an immune response with bnAb was found in 97% of Phase I participants who were vaccinated in the United States. A total of 48 healthy adult volunteers were recruited: they received either a placebo or two doses of eOD-GT8 60mer along with an adjuvant (immune response enhancer) from GSK.

The study authors believe that bnAb antibodies could be used against other complex pathogens such as influenza, Zika virus, dengue fever, hepatitis C, and so on.

The developers plan to join forces with biotech company Moderna to develop an mRNA-based vaccine that could significantly accelerate the pace of such a drug.

The Bill & Melinda Gates Foundation, the government of the Netherlands, the United States and several research institutes around the world are also involved in the AIDS vaccine project.

- Advertisement -
- Advertisement -

Latest News

Four signs Lumps and Bumps on your body could be cancerous – warn experts

Finding a new lump or bump on your body could give most of us pause. After all, a lump...
- Advertisement -

More Articles Like This

- Advertisement -